(Q38987129)

8 September 2017

title

Mutational and expressional analysis of ERBB3 gene in common solid cancers (English)

1 reference

8 September 2017

Mi Ryoung Choi

1

1 reference

8 September 2017

Chang Hyeok An

2

1 reference

8 September 2017

Yeun Jun Chung

3

1 reference

8 September 2017

Youn Jin Choi

4

1 reference

8 September 2017

Nam Jin Yoo

5

1 reference

8 September 2017

Sug Hyung Lee

6

1 reference

8 September 2017

publication date

7 June 2014

1 reference

Acta Pathologica et Microbiologica Scandinavica

8 September 2017

published in

1 reference

8 September 2017

volume

122

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

1207-1212

1 reference

The discovery of receptor tyrosine kinases: targets for cancer therapy

8 September 2017

cites work

1 reference

Epidermal growth factor receptor: mechanisms of activation and signalling.

21 January 2018

1 reference

The ErbB receptors and their role in cancer progression.

21 January 2018

1 reference

Trafficking of the ErbB receptors and its influence on signaling

21 January 2018

1 reference

ErbB-4: mechanism of action and biology

21 January 2018

1 reference

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

21 January 2018

1 reference

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

21 January 2018

1 reference

ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

21 January 2018

1 reference

Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3

21 January 2018

1 reference

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

21 January 2018

1 reference

ErbB receptors and signaling pathways in cancer

21 January 2018

1 reference

Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC.

21 January 2018

1 reference

Oncogenic ERBB3 mutations in human cancers

21 January 2018

1 reference

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

21 January 2018

1 reference

Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers

21 January 2018

1 reference

Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin

21 January 2018

1 reference

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

21 January 2018

1 reference

Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma

21 January 2018

1 reference

The promise of anti-ErbB3 monoclonals as new cancer therapeutics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APM.12286

1 reference

8 September 2017

1 reference